Answer
Taking Efavirenz/Emtricitabine/Tenofovir disoproxil Glenmark with praziquantel is not recommended because efavirenz increases hepatic metabolism of praziquantel, significantly decreasing its plasma concentrations and risking treatment failure.
Sources for this answer
- Efavirenz/Emtricitabine/Tenofovir disoproxil Glenmark 600 mg/ 200 mg/245 mg film-coated tabletsGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 5Document updated
Sources checked